(Q36965655)

17 August 2017

1 reference

title

Correlates of protective immunity in poxvirus infection: where does antibody stand? (English)

1 reference

17 August 2017

1 reference

Vijay Panchanathan

1 reference

17 August 2017

Geeta Chaudhri

series ordinal

1 reference

17 August 2017

Gunasegaran Karupiah

series ordinal

1 reference

17 August 2017

publication date

9 October 2007

1 reference

Immunology & Cell Biology

17 August 2017

published in

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

80-86

1 reference

Historical overview of vaccines

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

The Florey Lecture, 1983: Biological Control, as Exemplified by Smallpox Eradication and Myxomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

An overview of poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Myths in medicine. Jenner did not discover vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Benjamin Jesty: new light in the dawn of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

The looming threat of bioterrorism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Poxviruses and the origin of the eukaryotic nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Discovery of antivirals against smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Bioterrorism as a public health threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

The persistence of neutralizing antibodies after revaccination against smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Duration of antiviral immunity after smallpox vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Ectromelia virus: the causative agent of mousepox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Poxviruses and immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Expression of secreted cytokine and chemokine inhibitors by ectromelia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

The cell-mediated immune response to ectromelia virus infection. I. Kinetics and characteristics of the primary effector T cell response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Interferon function is not required for recovery from a secondary poxvirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Cytokines and immunity to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Induction of natural killer cell responses by ectromelia virus controls infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Obligatory requirement for antibody in recovery from a primary poxvirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Antibodies and CD8+ T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Viral mimicry of cytokines, chemokines and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Granzyme A is critical for recovery of mice from infection with the natural cytopathic viral pathogen, ectromelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Activation of Virus-specific Memory B Cells in the Absence of T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Fluctuations in the titre of antibody to a soluble antigen of myxoma virus in field populations of rabbits, Oryctolagus cuniculus (L.), in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Cellular and humoral immunity against vaccinia virus infection of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Neutralizing activities of antisera to poxvirus soluble antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Antibody neutralization of the extracellular enveloped form of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

A prominent antigenic surface polypeptide involved in the biogenesis and function of the vaccinia virus envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Neutralizing and protective antibodies directed against vaccinia virus envelope antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Subunit recombinant vaccine protects against monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

A prospective study of serum antibody and protection against smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Studies on the innate resistance of mice to infection with mousepox. II. Route of inoculation and resistance; and some observations on the inheritance of resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Mechanisms determining innate resistance to ectromelia virus infection in C57BL mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Soluble interferon-gamma receptors encoded by poxviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Perforin is essential for control of ectromelia virus but not related poxviruses in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100118

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100118

1 reference

Dimensions Publication ID

17 August 2017

1041738162

0 references

1 reference